Condition: Extracorporeal Membrane Oxygenation · Sponsor: Heinrich-Heine University, Duesseldorf
The availability as well as the use of extracorporeal membrane oxygenation (ECMO) systems for severe acute respiratory or cardiocirculatory failure is steadily increasing. The decision to initiate ECMO therapy is predominantly made in emergency situations, for which the focus is on acute survival. The decisions if a patient will profit from ECMO therapy are mainly made from clinical experience and educated guess by the attending team. However, it is unknown how useful these clinical predictions are. Therefore, this observational study will compare estimated and real outcome of ECMO patients.
This description comes directly from the study's public registry record.
René M'Pembele, MD · 02118118451 · rene.mpembele@med.uni-duesseldorf.de
Sebastian Roth, MD · 02118118451 · sebastian.roth@med.uni-duesseldorf.de
Always discuss trial participation with your own doctor first.
| University Hospital Duesseldorf | Düsseldorf, North Rhine-Westphalia, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06400797